nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifenprodil—GRIN2B—Parkinson's disease	0.806	1	CbGaD
Ifenprodil—GRIN1—telencephalic ventricle—Parkinson's disease	0.0103	0.135	CbGeAlD
Ifenprodil—GRIN2B—telencephalic ventricle—Parkinson's disease	0.0098	0.129	CbGeAlD
Ifenprodil—GRIN2B—nerve—Parkinson's disease	0.00617	0.081	CbGeAlD
Ifenprodil—GRIN1—hindbrain—Parkinson's disease	0.00485	0.0636	CbGeAlD
Ifenprodil—GRIN2B—hindbrain—Parkinson's disease	0.00462	0.0607	CbGeAlD
Ifenprodil—GRIN1—brainstem—Parkinson's disease	0.00278	0.0365	CbGeAlD
Ifenprodil—GRIN1—forebrain—Parkinson's disease	0.00268	0.0352	CbGeAlD
Ifenprodil—GRIN2B—brainstem—Parkinson's disease	0.00265	0.0348	CbGeAlD
Ifenprodil—GRIN2B—forebrain—Parkinson's disease	0.00256	0.0336	CbGeAlD
Ifenprodil—GRIN1—midbrain—Parkinson's disease	0.00177	0.0232	CbGeAlD
Ifenprodil—GRIN1—spinal cord—Parkinson's disease	0.00173	0.0227	CbGeAlD
Ifenprodil—GRIN2B—spinal cord—Parkinson's disease	0.00165	0.0216	CbGeAlD
Ifenprodil—GRIN1—head—Parkinson's disease	0.00154	0.0201	CbGeAlD
Ifenprodil—GRIN2B—head—Parkinson's disease	0.00146	0.0192	CbGeAlD
Ifenprodil—GRIN1—nervous system—Parkinson's disease	0.00146	0.0191	CbGeAlD
Ifenprodil—GRIN1—central nervous system—Parkinson's disease	0.0014	0.0184	CbGeAlD
Ifenprodil—GRIN2B—nervous system—Parkinson's disease	0.00139	0.0182	CbGeAlD
Ifenprodil—GRIN1—cerebellum—Parkinson's disease	0.00137	0.018	CbGeAlD
Ifenprodil—GRIN2B—central nervous system—Parkinson's disease	0.00134	0.0175	CbGeAlD
Ifenprodil—GRIN2B—cerebellum—Parkinson's disease	0.00131	0.0171	CbGeAlD
Ifenprodil—GRIN1—brain—Parkinson's disease	0.00111	0.0146	CbGeAlD
Ifenprodil—GRIN2B—brain—Parkinson's disease	0.00106	0.0139	CbGeAlD
Ifenprodil—KCNH2—forebrain—Parkinson's disease	0.000894	0.0117	CbGeAlD
Ifenprodil—SIGMAR1—medulla oblongata—Parkinson's disease	0.000811	0.0106	CbGeAlD
Ifenprodil—Diphenylpyraline—SLC6A3—Parkinson's disease	0.000791	0.352	CrCbGaD
Ifenprodil—KCNH2—cardiovascular system—Parkinson's disease	0.000756	0.00991	CbGeAlD
Ifenprodil—SIGMAR1—midbrain—Parkinson's disease	0.000741	0.00973	CbGeAlD
Ifenprodil—SIGMAR1—spinal cord—Parkinson's disease	0.000723	0.00949	CbGeAlD
Ifenprodil—HRH1—forebrain—Parkinson's disease	0.000716	0.0094	CbGeAlD
Ifenprodil—KCNH2—medulla oblongata—Parkinson's disease	0.000646	0.00847	CbGeAlD
Ifenprodil—KCNH2—midbrain—Parkinson's disease	0.00059	0.00774	CbGeAlD
Ifenprodil—KCNH2—spinal cord—Parkinson's disease	0.000576	0.00755	CbGeAlD
Ifenprodil—SIGMAR1—cerebellum—Parkinson's disease	0.000574	0.00752	CbGeAlD
Ifenprodil—KCNH2—head—Parkinson's disease	0.000512	0.00671	CbGeAlD
Ifenprodil—Hydroxyzine—CYP2D6—Parkinson's disease	0.000495	0.22	CrCbGaD
Ifenprodil—KCNH2—nervous system—Parkinson's disease	0.000485	0.00636	CbGeAlD
Ifenprodil—KCNH2—central nervous system—Parkinson's disease	0.000467	0.00613	CbGeAlD
Ifenprodil—SIGMAR1—brain—Parkinson's disease	0.000466	0.00611	CbGeAlD
Ifenprodil—KCNH2—cerebellum—Parkinson's disease	0.000457	0.00599	CbGeAlD
Ifenprodil—HRH1—head—Parkinson's disease	0.00041	0.00538	CbGeAlD
Ifenprodil—HRH1—nervous system—Parkinson's disease	0.000389	0.0051	CbGeAlD
Ifenprodil—HRH1—central nervous system—Parkinson's disease	0.000374	0.00491	CbGeAlD
Ifenprodil—KCNH2—brain—Parkinson's disease	0.000371	0.00486	CbGeAlD
Ifenprodil—Labetalol—CYP2D6—Parkinson's disease	0.000368	0.164	CrCbGaD
Ifenprodil—HRH1—brain—Parkinson's disease	0.000297	0.0039	CbGeAlD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.000276	0.00238	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000275	0.00238	CbGpPWpGaD
Ifenprodil—GRIN1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000272	0.00235	CbGpPWpGaD
Ifenprodil—GRIN1—Neuronal System—GRIK2—Parkinson's disease	0.000272	0.00235	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—GRIK1—Parkinson's disease	0.000267	0.00231	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000266	0.0023	CbGpPWpGaD
Ifenprodil—GRIN2B—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000265	0.0023	CbGpPWpGaD
Ifenprodil—GRIN2B—Neuronal System—GRIK2—Parkinson's disease	0.000265	0.00229	CbGpPWpGaD
Ifenprodil—GRIN1—Neuronal System—SLC18A2—Parkinson's disease	0.000264	0.00228	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000262	0.00227	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—NDUFB11—Parkinson's disease	0.000262	0.00226	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—DLG1—Parkinson's disease	0.000259	0.00224	CbGpPWpGaD
Ifenprodil—GRIN2B—Neuronal System—SLC18A2—Parkinson's disease	0.000257	0.00222	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—DLG1—Parkinson's disease	0.000252	0.00218	CbGpPWpGaD
Ifenprodil—Bepridil—CYP2D6—Parkinson's disease	0.000251	0.112	CrCbGaD
Ifenprodil—EBP—Metabolism—GCH1—Parkinson's disease	0.00025	0.00216	CbGpPWpGaD
Ifenprodil—GRIN1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00025	0.00216	CbGpPWpGaD
Ifenprodil—HRH1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000248	0.00215	CbGpPWpGaD
Ifenprodil—GRIN2B—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000243	0.0021	CbGpPWpGaD
Ifenprodil—GRIN1—BDNF signaling pathway—BDNF—Parkinson's disease	0.000239	0.00207	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000238	0.00206	CbGpPWpGaD
Ifenprodil—GRIN1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000234	0.00203	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.000233	0.00202	CbGpPWpGaD
Ifenprodil—GRIN2B—BDNF signaling pathway—BDNF—Parkinson's disease	0.000233	0.00202	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000232	0.00201	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000229	0.00198	CbGpPWpGaD
Ifenprodil—GRIN1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000229	0.00198	CbGpPWpGaD
Ifenprodil—GRIN2B—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000228	0.00197	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—GRIK2—Parkinson's disease	0.000227	0.00196	CbGpPWpGaD
Ifenprodil—GRIN1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000226	0.00195	CbGpPWpGaD
Ifenprodil—EBP—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000225	0.00195	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000224	0.00194	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—GBA—Parkinson's disease	0.000222	0.00192	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—FBP1—Parkinson's disease	0.000222	0.00192	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—DBH—Parkinson's disease	0.000222	0.00192	CbGpPWpGaD
Ifenprodil—GRIN2B—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00022	0.0019	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—SLC18A2—Parkinson's disease	0.00022	0.0019	CbGpPWpGaD
Ifenprodil—GRIN1—BDNF signaling pathway—NGF—Parkinson's disease	0.000212	0.00183	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.000209	0.00181	CbGpPWpGaD
Ifenprodil—GRIN1—Neuronal System—CHRNA4—Parkinson's disease	0.000209	0.0018	CbGpPWpGaD
Ifenprodil—GRIN2B—BDNF signaling pathway—NGF—Parkinson's disease	0.000207	0.00179	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000204	0.00177	CbGpPWpGaD
Ifenprodil—GRIN2B—Neuronal System—CHRNA4—Parkinson's disease	0.000203	0.00176	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—GDNF—Parkinson's disease	0.000203	0.00175	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000199	0.00172	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—GDNF—Parkinson's disease	0.000198	0.00171	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000193	0.00167	CbGpPWpGaD
Ifenprodil—GRIN1—Alzheimers Disease—IL1B—Parkinson's disease	0.000193	0.00167	CbGpPWpGaD
Ifenprodil—GRIN1—Alzheimers Disease—CASP3—Parkinson's disease	0.000193	0.00167	CbGpPWpGaD
Ifenprodil—GRIN1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000192	0.00166	CbGpPWpGaD
Ifenprodil—GRIN1—Neuronal System—HSPA8—Parkinson's disease	0.000191	0.00165	CbGpPWpGaD
Ifenprodil—GRIN1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00019	0.00165	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000189	0.00164	CbGpPWpGaD
Ifenprodil—GRIN2B—Alzheimers Disease—IL1B—Parkinson's disease	0.000189	0.00163	CbGpPWpGaD
Ifenprodil—GRIN2B—Alzheimers Disease—CASP3—Parkinson's disease	0.000188	0.00163	CbGpPWpGaD
Ifenprodil—GRIN2B—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000187	0.00162	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000187	0.00162	CbGpPWpGaD
Ifenprodil—GRIN2B—Neuronal System—HSPA8—Parkinson's disease	0.000186	0.00161	CbGpPWpGaD
Ifenprodil—GRIN2B—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000186	0.00161	CbGpPWpGaD
Ifenprodil—GRIN1—Neuronal System—DLG4—Parkinson's disease	0.000179	0.00155	CbGpPWpGaD
Ifenprodil—Bepridil—ABCB1—Parkinson's disease	0.000179	0.0797	CrCbGaD
Ifenprodil—GRIN1—Neuronal System—GRIN2B—Parkinson's disease	0.000175	0.00152	CbGpPWpGaD
Ifenprodil—GRIN2B—Neuronal System—DLG4—Parkinson's disease	0.000175	0.00151	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—CHRNA4—Parkinson's disease	0.000174	0.0015	CbGpPWpGaD
Ifenprodil—GRIN1—Neuronal System—SLC6A3—Parkinson's disease	0.000173	0.0015	CbGpPWpGaD
Ifenprodil—GRIN1—Axon guidance—HSPA8—Parkinson's disease	0.00017	0.00147	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.000169	0.00146	CbGpPWpGaD
Ifenprodil—GRIN2B—Neuronal System—SLC6A3—Parkinson's disease	0.000168	0.00146	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000166	0.00143	CbGpPWpGaD
Ifenprodil—GRIN2B—Axon guidance—HSPA8—Parkinson's disease	0.000165	0.00143	CbGpPWpGaD
Ifenprodil—Fentanyl—ABCB1—Parkinson's disease	0.000165	0.0733	CrCbGaD
Ifenprodil—EBP—Metabolism—DDC—Parkinson's disease	0.000163	0.00141	CbGpPWpGaD
Ifenprodil—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—Parkinson's disease	0.000163	0.00141	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—HSPA8—Parkinson's disease	0.000159	0.00138	CbGpPWpGaD
Ifenprodil—GRIN1—Axon guidance—DLG4—Parkinson's disease	0.000159	0.00138	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000158	0.00136	CbGpPWpGaD
Ifenprodil—GRIN1—Axon guidance—GRIN2B—Parkinson's disease	0.000156	0.00135	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—GPR37—Parkinson's disease	0.000155	0.00134	CbGpPWpGaD
Ifenprodil—GRIN2B—Axon guidance—DLG4—Parkinson's disease	0.000155	0.00134	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—GSTA4—Parkinson's disease	0.000154	0.00133	CbGpPWpGaD
Ifenprodil—EBP—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000152	0.00132	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.000151	0.00131	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—DLG4—Parkinson's disease	0.000149	0.00129	CbGpPWpGaD
Ifenprodil—GRIN1—Neuronal System—COMT—Parkinson's disease	0.000147	0.00127	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—GRIN2B—Parkinson's disease	0.000146	0.00126	CbGpPWpGaD
Ifenprodil—GRIN1—Neuronal System—MAOA—Parkinson's disease	0.000146	0.00126	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—SLC6A3—Parkinson's disease	0.000144	0.00125	CbGpPWpGaD
Ifenprodil—GRIN2B—Neuronal System—COMT—Parkinson's disease	0.000143	0.00124	CbGpPWpGaD
Ifenprodil—GRIN2B—Neuronal System—MAOA—Parkinson's disease	0.000142	0.00123	CbGpPWpGaD
Ifenprodil—GRIN1—Alzheimers Disease—TNF—Parkinson's disease	0.00014	0.00121	CbGpPWpGaD
Ifenprodil—GRIN1—Spinal Cord Injury—IL1B—Parkinson's disease	0.00014	0.00121	CbGpPWpGaD
Ifenprodil—GRIN1—Spinal Cord Injury—CASP3—Parkinson's disease	0.00014	0.00121	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—PLA2G6—Parkinson's disease	0.000139	0.0012	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—MAOB—Parkinson's disease	0.000137	0.00119	CbGpPWpGaD
Ifenprodil—GRIN2B—Alzheimers Disease—TNF—Parkinson's disease	0.000137	0.00118	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000131	0.00114	CbGpPWpGaD
Ifenprodil—EBP—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000131	0.00113	CbGpPWpGaD
Ifenprodil—GRIN1—Axon guidance—ABL1—Parkinson's disease	0.000127	0.0011	CbGpPWpGaD
Ifenprodil—GRIN2B—Axon guidance—ABL1—Parkinson's disease	0.000124	0.00107	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.000123	0.00106	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—COMT—Parkinson's disease	0.000122	0.00106	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—MAOA—Parkinson's disease	0.000122	0.00105	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—HSPA8—Parkinson's disease	0.000121	0.00105	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00012	0.00104	CbGpPWpGaD
Ifenprodil—GRIN1—BDNF signaling pathway—CASP3—Parkinson's disease	0.000119	0.00103	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—HSPA8—Parkinson's disease	0.000118	0.00102	CbGpPWpGaD
Ifenprodil—GRIN2B—BDNF signaling pathway—CASP3—Parkinson's disease	0.000116	0.00101	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—DLG4—Parkinson's disease	0.000114	0.000983	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000112	0.000971	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000112	0.000969	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—GRIN2B—Parkinson's disease	0.000111	0.00096	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000111	0.00096	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—DLG4—Parkinson's disease	0.000111	0.000958	CbGpPWpGaD
Ifenprodil—GRIN1—BDNF signaling pathway—MAPK8—Parkinson's disease	0.00011	0.000949	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00011	0.000949	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.000109	0.000941	CbGpPWpGaD
Ifenprodil—GRIN2B—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000107	0.000925	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—GRM4—Parkinson's disease	0.000106	0.000914	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—CYP2D6—Parkinson's disease	0.000102	0.000884	CbGpPWpGaD
Ifenprodil—GRIN1—Spinal Cord Injury—TNF—Parkinson's disease	0.000102	0.000881	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—CTGF—Parkinson's disease	0.0001	0.000868	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—PENK—Parkinson's disease	0.0001	0.000866	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	9.73e-05	0.000842	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	9.63e-05	0.000833	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	9.51e-05	0.000822	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	9.35e-05	0.000809	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—CYP2E1—Parkinson's disease	9.34e-05	0.000808	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	9.33e-05	0.000807	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	9.3e-05	0.000804	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—NQO1—Parkinson's disease	9.24e-05	0.000799	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—PDYN—Parkinson's disease	9.16e-05	0.000792	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—TH—Parkinson's disease	9.11e-05	0.000788	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—ABL1—Parkinson's disease	9.05e-05	0.000783	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	9.01e-05	0.000779	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—ABL1—Parkinson's disease	8.82e-05	0.000763	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—DGKQ—Parkinson's disease	8.78e-05	0.00076	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—CYCS—Parkinson's disease	8.74e-05	0.000756	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—GRM5—Parkinson's disease	8.51e-05	0.000737	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—EDN1—Parkinson's disease	8.43e-05	0.00073	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	8.25e-05	0.000714	CbGpPWpGaD
Ifenprodil—GRIN1—Spinal Cord Injury—IL6—Parkinson's disease	8.22e-05	0.000711	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	8.14e-05	0.000705	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	8.14e-05	0.000705	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	8.14e-05	0.000705	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	8.12e-05	0.000703	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—DGKQ—Parkinson's disease	7.97e-05	0.00069	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—GPR37—Parkinson's disease	7.97e-05	0.00069	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	7.97e-05	0.000689	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—COMT—Parkinson's disease	7.74e-05	0.00067	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	7.72e-05	0.000668	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—GSTP1—Parkinson's disease	7.71e-05	0.000667	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—MAOA—Parkinson's disease	7.69e-05	0.000665	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—HMOX1—Parkinson's disease	7.6e-05	0.000658	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	7.54e-05	0.000653	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	7.38e-05	0.000638	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—ABCB1—Parkinson's disease	7.29e-05	0.000631	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	7.29e-05	0.000631	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	7.24e-05	0.000626	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—GSTM1—Parkinson's disease	7.08e-05	0.000613	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	6.98e-05	0.000604	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	6.98e-05	0.000604	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	6.78e-05	0.000587	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—GPX1—Parkinson's disease	6.78e-05	0.000587	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	6.65e-05	0.000576	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	6.6e-05	0.000571	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	6.57e-05	0.000569	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	6.28e-05	0.000543	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—MTHFR—Parkinson's disease	6.26e-05	0.000541	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	6.19e-05	0.000535	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	6.07e-05	0.000525	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	6.04e-05	0.000523	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—INS—Parkinson's disease	5.98e-05	0.000517	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	5.97e-05	0.000516	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	5.88e-05	0.000508	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—INS—Parkinson's disease	5.83e-05	0.000504	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—APOE—Parkinson's disease	5.83e-05	0.000504	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	5.7e-05	0.000493	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—VPS35—Parkinson's disease	5.68e-05	0.000492	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	5.66e-05	0.00049	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	5.59e-05	0.000483	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.47e-05	0.000474	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	5.42e-05	0.000469	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	5.31e-05	0.00046	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	5.31e-05	0.00046	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	5.18e-05	0.000448	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—PENK—Parkinson's disease	5.14e-05	0.000445	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—INS—Parkinson's disease	4.98e-05	0.000431	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	4.89e-05	0.000423	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	4.81e-05	0.000416	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	4.71e-05	0.000408	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—GPR37—Parkinson's disease	4.71e-05	0.000408	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	4.7e-05	0.000407	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	4.37e-05	0.000378	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	4.31e-05	0.000373	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	4.25e-05	0.000368	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	4.09e-05	0.000354	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—RIT2—Parkinson's disease	3.77e-05	0.000326	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	3.72e-05	0.000322	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	3.71e-05	0.000321	CbGpPWpGaD
Ifenprodil—GRIN1—Axon guidance—IL6—Parkinson's disease	3.66e-05	0.000317	CbGpPWpGaD
Ifenprodil—GRIN2B—Axon guidance—IL6—Parkinson's disease	3.57e-05	0.000309	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—GRK5—Parkinson's disease	3.57e-05	0.000309	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	3.55e-05	0.000307	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	3.5e-05	0.000302	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	3.43e-05	0.000297	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	3.32e-05	0.000287	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—TNF—Parkinson's disease	3.24e-05	0.00028	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	3.22e-05	0.000279	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—GRM4—Parkinson's disease	3.2e-05	0.000277	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	3.17e-05	0.000275	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—TNF—Parkinson's disease	3.16e-05	0.000273	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	3.11e-05	0.000269	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.1e-05	0.000268	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—PENK—Parkinson's disease	3.04e-05	0.000263	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—MAG—Parkinson's disease	3.04e-05	0.000263	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	3.02e-05	0.000261	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	3e-05	0.00026	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	3e-05	0.00026	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	2.82e-05	0.000244	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—PDYN—Parkinson's disease	2.78e-05	0.00024	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	2.73e-05	0.000236	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	2.73e-05	0.000236	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—IL6—Parkinson's disease	2.61e-05	0.000226	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—GFAP—Parkinson's disease	2.61e-05	0.000226	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—GRM5—Parkinson's disease	2.58e-05	0.000223	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—IL6—Parkinson's disease	2.55e-05	0.00022	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	2.4e-05	0.000208	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	2.29e-05	0.000198	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—FGF20—Parkinson's disease	2.26e-05	0.000196	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	2.19e-05	0.00019	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	2.18e-05	0.000189	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	2.1e-05	0.000182	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—INSR—Parkinson's disease	2.03e-05	0.000175	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—FGB—Parkinson's disease	1.91e-05	0.000166	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	1.91e-05	0.000165	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	1.9e-05	0.000165	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—TAC1—Parkinson's disease	1.88e-05	0.000162	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—DRD1—Parkinson's disease	1.84e-05	0.000159	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—DRD3—Parkinson's disease	1.78e-05	0.000154	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	1.66e-05	0.000144	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—HTR7—Parkinson's disease	1.61e-05	0.000139	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—DRD2—Parkinson's disease	1.61e-05	0.000139	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—IGF2—Parkinson's disease	1.35e-05	0.000117	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	1.31e-05	0.000113	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—EDN1—Parkinson's disease	1.29e-05	0.000112	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—NGF—Parkinson's disease	1.19e-05	0.000103	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	1.13e-05	9.76e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—APOE—Parkinson's disease	1.05e-05	9.07e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—INS—Parkinson's disease	8.96e-06	7.75e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CASP3—Parkinson's disease	6.67e-06	5.77e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—IL6—Parkinson's disease	6.63e-06	5.73e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	6.13e-06	5.3e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—IL6—Parkinson's disease	3.92e-06	3.39e-05	CbGpPWpGaD
